Table 1. Characteristics of MRSA and MSSA responsible for BSI during the 5-year period.
Year | Number | BSI | Sex of the patient | Portal of entry of the BSI | Death2 | |||||||||
of BSI | incidence | M | F | Skin | Surgical Site | Pulmonary | Urinary | IVD1 | Digestive | others | Unknown | within 7 days | ||
MSSA | 670 | 0.275 | 442 | 228 | 136 | 82 | 57 | 43 | 128 | 21 | 51 | 152 | 54 (83 nk) | |
CA | all | 251 | 0.103 | 162 | 89 | 86 | 27 | 13 | 6 | 33 | 86 | 21 (27 nk) | ||
2007 | 50 | 0.083 | 28 | 22 | 12 | 6 | 2 | 3 | 12 | 15 | 3 (2 nk) | |||
2008 | 64 | 0.103 | 42 | 22 | 24 | 7 | 5 | 3 | 25 | 6 (2 nk) | ||||
2009 | 66 | 0.105 | 45 | 21 | 23 | 4 | 5 | 3 | 11 | 20 | 3 (10 nk) | |||
2010 | 71 | 0.121 | 47 | 24 | 27 | 10 | 1 | 7 | 26 | 9 (13 nk) | ||||
HA | all | 419 | 0.172 | 280 | 139 | 50 | 82 | 30 | 30 | 128 | 15 | 18 | 66 | 33 (56 nk) |
2007 | 101 | 0.167 | 69 | 32 | 14 | 21 | 6 | 10 | 30 | 3 | 3 | 14 | 15 (1 nk) | |
2008 | 97 | 0.156 | 68 | 29 | 12 | 18 | 7 | 6 | 27 | 3 | 5 | 19 | 11 (1 nk) | |
2009 | 103 | 0.164 | 73 | 30 | 12 | 18 | 9 | 7 | 32 | 4 | 4 | 17 | 4 (26 nk) | |
2010 | 118 | 0.201 | 70 | 48 | 12 | 25 | 8 | 7 | 39 | 5 | 6 | 16 | 3 (28 nk) | |
MRSA | 188 | 0.077 | 124 | 64 | 45 | 18 | 21 | 25 | 30 | 5 | 5 | 39 | 26 (20 nk) | |
CA | all | 51 | 0.021 | 36 | 15 | 18 | 7 | 7 | 2 | 17 | 4 (7 nk) | |||
2007 | 9 | 0.015 | 5 | 4 | 1 | 1 | 2 | 5 | 2 (1 nk) | |||||
2008 | 15 | 0.024 | 9 | 6 | 5 | 3 | 3 | 4 | 2 | |||||
2009 | 13 | 0.021 | 11 | 2 | 5 | 2 | 1 | 5 | 0 (4 nk) | |||||
2010 | 14 | 0.024 | 11 | 3 | 7 | 3 | 1 | 3 | 0 (2 nk) | |||||
HA | all | 137 | 0.056 | 88 | 49 | 27 | 18 | 14 | 18 | 30 | 5 | 3 | 22 | 22 (13 nk) |
2007 | 43 | 0.071 | 28 | 15 | 6 | 6 | 4 | 4 | 11 | 3 | 2 | 7 | 7 (1 nk) | |
2008 | 33 | 0.053 | 20 | 13 | 10 | 6 | 4 | 2 | 5 | 1 | 5 | 5 (1 nk) | ||
2009 | 29 | 0.046 | 19 | 10 | 5 | 2 | 3 | 7 | 6 | 1 | 5 | 5 (5 nk) | ||
2010 | 32 | 0.055 | 21 | 11 | 6 | 4 | 3 | 5 | 8 | 1 | 5 | 5 (6 nk) | ||
All | 858 | 0.352 | 566 | 292 | 181 | 100 | 78 | 68 | 158 | 26 | 56 | 191 | 80 (103 nk) | |
CA | 302 | 0.124 | 198 | 104 | 104 | 34 | 20 | 6 | 35 | 103 | 25 (34 nk) | |||
HA | 556 | 0.228 | 368 | 188 | 77 | 100 | 44 | 48 | 158 | 20 | 21 | 88 | 55 (69 nk) |
Intra-Venous Devices
nk not known.